Beyond its well-known role as genome caretaker, p53 was also found to be a critical regulator of metabolic adaptation in several cancer types, including embryonal brain tumors (Marie and Shinjo, 2011; Xiong et al., 2020). The gene discussed is TP53; the disease is cancer.